{"id":"https://openalex.org/W7216304416","doi":"https://doi.org/10.1007/s13555-026-01886-9","title":"Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2","display_name":"Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2","publication_year":2026,"publication_date":"2026-10-02","ids":{"openalex":"https://openalex.org/W7216304416","doi":"https://doi.org/10.1007/s13555-026-01886-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/42825995","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13696655"},"language":"en","primary_location":{"id":"doi:10.1007/s13555-026-01886-9","doi":"https://doi.org/10.1007/s13555-026-01886-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01886-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01886-9.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01886-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028901907","display_name":"Ruth Ann Vleugels","orcid":"https://orcid.org/0000-0001-8446-7115","observed_orcids":["https://orcid.org/0000-0001-8446-7115"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ruth Ann Vleugels","raw_affiliation_strings":["Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Brigham and Women's at 221 Longwood, Boston, MA, 02115, USA. rvleugels@bwh.harvard.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Brigham and Women's at 221 Longwood, Boston, MA, 02115, USA. rvleugels@bwh.harvard.edu","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5155276858","display_name":"Bianca Maria Piraccini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bianca Maria Piraccini","raw_affiliation_strings":["Piraccini Medical Center, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Piraccini Medical Center, Bologna, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153587467","display_name":"Natasha Mesinkovska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natasha Mesinkovska","raw_affiliation_strings":["Department of Dermatology, University of California, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of California, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083722360","display_name":"Arash Mostaghimi","orcid":"https://orcid.org/0000-0002-6084-5617","observed_orcids":["https://orcid.org/0000-0002-6084-5617"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arash Mostaghimi","raw_affiliation_strings":["Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Brigham and Women's at 221 Longwood, Boston, MA, 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Brigham and Women's at 221 Longwood, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063392694","display_name":"Yutaka Shimomura","orcid":"https://orcid.org/0000-0001-9727-8073","observed_orcids":["https://orcid.org/0000-0001-9727-8073"]},"institutions":[{"id":"https://openalex.org/I173915773","display_name":"Yamaguchi University","ror":"https://ror.org/03cxys317","country_code":"JP","type":"education","lineage":["https://openalex.org/I173915773"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Shimomura","raw_affiliation_strings":["Department of Dermatology, Yamaguchi University School of Medicine, Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Yamaguchi University School of Medicine, Yamaguchi, Japan","institution_ids":["https://openalex.org/I173915773"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070589662","display_name":"Angelina Sontag","orcid":"https://orcid.org/0000-0003-4012-4537","observed_orcids":["https://orcid.org/0000-0003-4012-4537"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angelina Sontag","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5156033148","display_name":"Fionn McSwiney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fionn McSwiney","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053940783","display_name":"Najwa Somani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Najwa Somani","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5154284134","display_name":"Hitendra Pandey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hitendra Pandey","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114675873","display_name":"Karen Denning","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Denning","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5152683398","display_name":"Brett King","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett King","raw_affiliation_strings":["Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5028901907"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.7859633,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"11","first_page":"5619","last_page":"5633"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":0.8820000290870667},{"id":"https://openalex.org/keywords/severe-alopecia-areata","display_name":"severe alopecia areata","score":0.9359999895095825},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7910000085830688},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.8989999890327454},{"id":"https://openalex.org/keywords/salt-score","display_name":"SALT score","score":0.7860000133514404},{"id":"https://openalex.org/keywords/severe-infection","display_name":"serious infections","score":0.8169999718666077},{"id":"https://openalex.org/keywords/non-melanoma-skin-cancer","display_name":"non-melanoma skin cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.8519999980926514},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9598000049591064},{"id":"https://openalex.org/C2777524370","wikidata":"https://www.wikidata.org/wiki/Q5075435","display_name":"Alopecia areata","level":2,"score":0.616100013256073},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.5630999803543091},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.460099995136261},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3917999863624573},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3896999955177307},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.38269999623298645},{"id":"https://openalex.org/C2777789703","wikidata":"https://www.wikidata.org/wiki/Q192102","display_name":"Skin cancer","level":3,"score":0.38260000944137573},{"id":"https://openalex.org/C2776360568","wikidata":"https://www.wikidata.org/wiki/Q2697787","display_name":"Hair loss","level":2,"score":0.375},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3747999966144562},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.3546000123023987},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3443000018596649},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.3003000020980835},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.299699991941452},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2752000093460083},{"id":"https://openalex.org/C2910384678","wikidata":"https://www.wikidata.org/wiki/Q6744211","display_name":"Mallinckrodt","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.27079999446868896}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13555-026-01886-9","doi":"https://doi.org/10.1007/s13555-026-01886-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01886-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01886-9.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13696655","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696655/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696655/pdf/13555_2026_Article_1886.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatol Ther (Heidelb)","raw_type":"Text"},{"id":"pmid:42825995","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42825995","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:8efe7f56cbe1458e9150f2b5db463785","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8efe7f56cbe1458e9150f2b5db463785","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dermatology and Therapy, Vol 16, Iss 11, Pp 5619-5633 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s13555-026-01886-9","doi":"https://doi.org/10.1007/s13555-026-01886-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01886-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01886-9.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7216304416.pdf","grobid_xml":"https://content.openalex.org/works/W7216304416.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1963845724","https://openalex.org/W2787750967","https://openalex.org/W2946995879","https://openalex.org/W3012029807","https://openalex.org/W3049657126","https://openalex.org/W3084486220","https://openalex.org/W3087665791","https://openalex.org/W3137112599","https://openalex.org/W3206560512","https://openalex.org/W3206870195","https://openalex.org/W4211012025","https://openalex.org/W4220917957","https://openalex.org/W4294622199","https://openalex.org/W4309317329","https://openalex.org/W4322621664","https://openalex.org/W4365136331","https://openalex.org/W4385683576","https://openalex.org/W4385997353","https://openalex.org/W4387420790","https://openalex.org/W4392111062","https://openalex.org/W4401577096","https://openalex.org/W4404219202","https://openalex.org/W4409369841","https://openalex.org/W4414169075"],"related_works":["https://openalex.org/W4416141435","https://openalex.org/W4392111062","https://openalex.org/W4322621664","https://openalex.org/W4416703096","https://openalex.org/W4382025296","https://openalex.org/W4411495698","https://openalex.org/W4414437160","https://openalex.org/W4402109140","https://openalex.org/W4409369841","https://openalex.org/W4386981883"],"abstract_inverted_index":{"Long-term":[0],"efficacy":[1,64,444],"and":[2,29,51,65,111,129,179,196,206,226,254,268,357,368,393,416,439,448,490,495,545],"safety":[3,31,66,298,510,547],"data":[4],"are":[5,397,534],"imperative":[6],"for":[7,46,77,135,170,243,295,421,474,551],"therapies":[8],"used":[9],"to":[10,27,34,80,234,262,365,384,409,493,553],"treat":[11,410],"severe":[12,47,72,369,411,530],"alopecia":[13,412,436,531],"areata":[14,333,413,532],"(AA)":[15],"because":[16],"the":[17,30,61,114,154,171,241,340,354,378,390,428,488,506,513,546],"disease":[18,337,360,379],"is":[19,52,159,334,400,407,417],"chronic,":[20],"loss":[21,352],"of":[22,67,91,121,141,190,219,237,281,305,395,455,466,478,526,556],"response":[23,89],"can":[24,361],"be":[25,362,496],"devastating":[26,364],"patients,":[28],"profile":[32,299,502,511,548],"needs":[33],"support":[35],"long-term":[36,63,382,391,518],"therapy.":[37],"Baricitinib,":[38],"a":[39,124,131,210,401],"selective":[40],"JAK":[41],"inhibitor,":[42],"has":[43],"been":[44],"approved":[45,408],"AA":[48,174,182],"in":[49,55,69,307,414,423,433,445,483,512],"adults":[50,70,415,434,528],"being":[53,419],"studied":[54,420],"pediatric":[56],"patients.":[57],"This":[58,425],"study":[59,519],"evaluates":[60],"final":[62],"baricitinib":[68,81,193,509,537],"with":[71,145,239,292,309,435,468,505,529,536],"AA.":[73],"Efficacy":[74],"was":[75,227],"assessed":[76],"patients":[78,122,458],"randomized":[79],"4":[82,194,290,453,476],"mg":[83,86,195],"or":[84,143,349],"2":[85,106,197],"who":[87,459,533],"achieved":[88],"(Severity":[90],"Alopecia":[92,332],"Tool":[93],"[SALT]":[94],"score":[95,126,140,212],"\u2264":[96,127,213,286],"20)":[97],"at":[98,168,215],"Week":[99,118,201,216,224,230],"52":[100,202,225],"(4":[101],"mg,":[102,107,198],"N":[103,108],"=":[104,109,177,185],"133;":[105],"72)":[110],"stayed":[112],"on":[113,353],"same":[115],"dose":[116],"through":[117,187,229,288],"200.":[119,217,231],"Proportions":[120],"maintaining":[123,449],"SALT":[125,211,284],"20":[128,214,287],"achieving":[130],"Clinician-Reported":[132],"Outcome":[133],"Measure":[134],"Eyebrow/Eyelash":[136],"(EB/EL)":[137],"Hair":[138,481],"Loss\u2122":[139],"0":[142],"1":[144,464],"\u2265":[146],"2-point":[147],"improvement":[148],"from":[149,430],"baseline":[150],"were":[151],"reported":[152,160,508],"using":[153],"modified":[155],"last-observation-carried-forward":[156],"method.":[157],"Safety":[158],"as":[161,487],"incidence":[162],"rates":[163,271],"(IR)":[164],"per":[165],"100":[166],"patient-years":[167],"risk":[169],"All":[172],"BARI":[173,181],"group":[175,183],"(N":[176,184],"1303)":[178],"Extended":[180],"948)":[186],"248":[188],"weeks":[189],"exposure":[191,238],"For":[192],"respectively,":[199],"among":[200],"responders,":[203],"115/133":[204],"(86.5%)":[205],"61/72":[207],"(84.7%)":[208],"maintained":[209,228,283,471,497],"Regrowth":[218],"EB/EL":[220],"hair":[221,345,351,386,447,462,539],"continued":[222,293,479,492],"beyond":[223],"In":[232],"up":[233,552],"5":[235,303,554],"years":[236,291,304,454,477,555],"baricitinib,":[240,469],"IR":[242],"serious":[244],"infections,":[245],"nonmelanoma":[246],"skin":[247],"cancer":[248],"malignancies,":[249],"deep":[250],"vein":[251],"thrombosis/pulmonary":[252],"embolism,":[253],"major":[255],"adverse":[256,269],"cardiovascular":[257],"events":[258],"remained":[259,272,300],"low":[260],"relative":[261],"background":[263],"rates.":[264],"No":[265],"deaths":[266],"occurred,":[267],"event":[270],"stable":[273],"over":[274,302,452,498],"time.":[275,499],"Within":[276],"this":[277,517],"population,":[278],"~":[279,523],"85%":[280,470],"responders":[282],"scores":[285],"approximately":[289,475],"benefit":[294],"EB/EL.":[296],"Baricitinib\u2019s":[297],"consistent":[301,504,550],"treatment,":[306],"line":[308],"prior":[310],"BRAVE":[311,514],"program":[312],"findings.":[313],"BRAVE-AA1,":[314],"ClinicalTrials.gov":[315,324],"number,":[316,325],"NCT03570749,":[317],"start":[318,327],"date,":[319,328],"September":[320],"24,":[321],"2018;":[322],"BRAVE-AA2,":[323,440],"NCT03899259,":[326],"July":[329],"8,":[330],"2019.":[331],"an":[335],"autoimmune":[336],"caused":[338],"when":[339],"immune":[341],"system":[342],"mistakenly":[343],"attacks":[344],"follicles,":[346],"causing":[347],"patchy":[348],"complete":[350],"scalp,":[355],"face,":[356],"body.":[358],"The":[359,500],"emotionally":[363],"those":[366],"affected,":[367],"cases":[370],"do":[371],"not":[372],"usually":[373],"improve":[374,494],"without":[375],"treatment.":[376,456,480,557],"Since":[377],"often":[380],"requires":[381],"treatment":[383,396,467],"maintain":[385,538],"regrowth,":[387],"studies":[388,432],"examining":[389],"benefits":[392],"risks":[394],"important.":[398],"Baricitinib":[399],"medication":[402],"taken":[403],"by":[404],"mouth":[405],"which":[406],"also":[418],"use":[422],"children.":[424],"report":[426],"describes":[427],"results":[429],"two":[431],"areata,":[437],"BRAVE-AA1":[438],"that":[441,450,472,522],"tested":[442],"baricitinib's":[443],"regrowing":[446],"regrowth":[451,473,482,540],"Among":[457],"regrew":[460],"their":[461],"after":[463],"year":[465],"other":[484],"areas":[485],"such":[486],"eyebrows":[489],"eyelashes":[491],"observed":[501],"remains":[503,549],"previously":[507],"program.":[515],"Overall,":[516],"provides":[520],"evidence":[521],"9":[524],"out":[525],"10":[527],"treated":[535],"once":[541],"they":[542],"achieve":[543],"it,":[544]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-10-03T00:00:00"}